Form 4: NewAmsterdam Pharma Director James Topper Boosts Stake with $19.50 Share Purchase

James N. Topper, a Director and 10% Owner of NewAmsterdam Pharma Co N.V., has acquired 8,584 ordinary shares at a weighted average price of $19.4992 per share.

Summary

• James N. Topper, a Director and 10% Owner of NewAmsterdam Pharma Co N.V. (NAMS), purchased 8,584 ordinary shares.
• The transaction occurred on June 16, 2025, at a weighted average price of $19.4992 per share.
• The shares were acquired in multiple transactions ranging from $19.20 to $19.50.
• Following this transaction, Mr. Topper's indirect beneficial ownership includes 3,022,153 ordinary shares held by Frazier Life Sciences X, L.P., and 3,801,000 ordinary shares held by Frazier Lifesciences Sponsor LLC.
• Mr. Topper disclaims beneficial ownership of these indirectly held securities except to the extent of his pecuniary interest therein.

Sentiment

Score: 7

Explanation: The sentiment is positive due to a significant insider purchase by a director and 10% owner, indicating confidence in the company's prospects.

Positives

• The purchase of shares by a Director and 10% Owner signals confidence in the company's future prospects.
• Insider buying can be viewed positively by the market, suggesting management believes the stock is undervalued or has significant upside potential.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction reflects a specific investment decision by a key individual within NewAmsterdam Pharma Co N.V. and does not directly provide broader industry trends or competitive analysis. However, insider buying in the biotechnology or pharmaceutical sector can sometimes indicate confidence in upcoming clinical trial results, regulatory approvals, or commercialization efforts.

Stakeholder Impact

• Shareholders: The insider purchase may instill greater confidence among existing shareholders and attract new investors, potentially leading to positive share price movement.
• Employees: While not directly impacted, a positive market reaction could indirectly boost employee morale.

Key Dates

Recommendation

Keywords

NewAmsterdam Pharma, NAMS, James N. Topper, Director, Insider Trading, Share Purchase, SEC Form 4, Beneficial Ownership, Frazier Life Sciences